Vol. 39 No. 4 (2020): JMB
Scindeks Assistant SCIndeks Assistant
JMB

Original paper

Alenka Trampuš Bakija, Janez Jazbec, Barbara Faganel Kotnik
422-427
PLATELET LUMIAGGREGATION TESTING: REFERENCE INTERVALS AND THE EFFECT OF ACETYLSALICYLIC ACID IN HEALTHY ADULTS
PDF
İsmail Sarı
428-435
ASSOCIATION OF THE SEH GENE PROMOTER POLYMORPHISMS AND HAPLOTYPES WITH PREECLAMPSIA: Association of the EPHX2 promoter polymorphisms and preeclampsia
PDF
Olgica B. Mihaljević, Snežana Živančević-Simonović, Aleksandra Lučić-Tomić, Irena Živković, Rajna Minić, Ljiljana Mijatović-Todotović, Zorica Jovanović, Marija Anđelković, Marijana Stanojević-Pirković
436-443
THE ASSOCIATION OF CIRCULATING SCLEROSTIN LEVEL WITH MARKERS OF BONE METABOLISM IN PATIENTS WITH THYROID DYSFUNCTION
PDF
Shujun Liu, Yadi Zhu, Chenxi Zhang, Jiajia Liu, Hong Lv, Guojun Zhang, Xixiong Kang
444-451
SOLUBLE PROGRAMMED DEATH-1 (SPD-1) AND PROGRAMMED DEATH LIGAND 1 (SPD-L1) AS POTENTIAL BIOMARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF GLIOMA PATIENTS
PDF
Emre Avci, Alpaslan Karabulut, Gulcin Alp Avci, Burcu Baba, Cumhur Bilgi
452-459
CRUCIAL MARKERS SHOWING THE RISK OF CORONARY ARTERY DISEASE IN OBESITY: ADMA AND NEOPTERIN
PDF
Murugaiyan Vasanthi, Prashant Shankarrao Adole, Vinay Ramakrishna Pandit, Kolar Vishwanath Vinod
460-466
ASSESSMENT OF SERUM TENASCIN-C AND GROWTH DIFFERENTIATION FACTOR-15 AMONG TYPE 2 DIABETES MELLITUS PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROME
PDF
Phebe Lotfy Abdel-Messeih, Manal Mohamed Alkady, Neveen Mostafa Nosseir, Mohamed Said Tawfik
481-487
INFLAMMATORY MARKERS IN END-STAGE RENAL DISEASE PATIENTS ON HAEMODIALYSIS
PDF
Biljana Stankovic, Nikola Kotur, Vladimir Gasic, Kristel Klaassen, Bojan Ristivojevic, Maja Stojiljkovic, Sonja Pavlovic, Branka Zukić
488-499
Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations: Pharmacogenomics of potential drugs for COVID-19 therapy in Serbia
PDF
Maryame Ahnach, saad , Sara, fadwa, Pr elkettani
500-507
C-Reactive Protein as an early predictor of COVID-19 severity: C-Reactive Protein and COVID-19 severity.
PDF
Jelena Vekić, Jasmina Ivanišević, Aleksandra Zeljković, Vesna Spasojević-Kalimanovska, Nataša Bogavac-Stanojević, Marija Mihajlović, Jelena Janać, Sanja Vujčić, Milica Miljković, Dejan Žujović, Jelena Kotur-Stevuljević
467-473
EFFECT OF PROPOLIS AND N-ACETYLCYSTEINE SUPPLEMENTATION ON LIPOPROTEIN SUBCLASSES DISTRIBUTION AND PARAOXONASE 1 ACTIVITY IN SUBJECTS WITH ACUTE RESPIRATORY INFECTION
PDF
Adolfo Romero, Juan Gómez-Salgado, Adolfo Romero-Arana, José Antonio Gómez-Fernández, Andrés Cobos, María Carmen Ramos, María Rosa Iglesias
474-480
PREANALYTICAL ERRORS IN EMERGENCY DEPARTMENT SAMPLES: INVESTIGATING ERROR SOURCES
PDF